Holen Sie sich die Stockscreener-App
4.32
0.23%
-0.010
Handel nachbörslich:
4.33
0.010
+0.23%
Finanzdaten der Lumos Pharma Inc-Aktie (LUMO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
80.02%
0.165
|
0.826 | 0.007 | 0.527 | 0.691 |
Operating Expenses
|
1.82%
11.03
|
10.83 | 8.939 | 10.17 | 8.726 |
| Benefits Costs and Expenses |
100.00%
-
|
10.28 | 8.307 | 9.487 | - |
| Costs And Expenses |
7.24%
11.03
|
10.28 | 8.307 | 9.487 | 8.726 |
| Operating Income/Loss |
8.58%
-10.86
|
-10.00 | -8.932 | -9.643 | -8.035 |
| Nonoperating Income/Loss |
23.03%
0.421
|
0.547 | 0.632 | 0.683 | 0.689 |
| Income/Loss From Continuing Operations Before Tax |
101.74%
0.165
|
-9.457 | -8.30 | -8.96 | -7.346 |
| Income Tax Expense/Benefit |
-
|
- | - | -0.029 | - |
| Income/Loss From Continuing Operations After Tax |
10.40%
-10.44
|
-9.457 | -8.30 | -8.931 | -7.346 |
|
Net Income/Loss
|
10.40%
-10.44
|
-9.457 | -8.30 | -8.931 | -7.346 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
48,490%
8.1049
|
-0.0167 | 7.9785 | 8.1646 | 8.2399 |
| Diluted Average Shares |
48,490%
8.1049
|
-0.0167 | 7.9785 | 8.1646 | 8.2399 |
| Basic Earnings Per Share |
10.26%
-1.29
|
-1.17 | -1.04 | -1.09 | -0.89 |
| Diluted Earnings Per Share |
10.26%
-1.29
|
-1.17 | -1.04 | -1.09 | -0.89 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):